|
|
| | 2,4-Quinazolinediamine, N4-(5-ethyl-1H-pyrazol-3-yl)-N2-[(1S)-1-(4-fluorophenyl)ethyl]- Basic information |
| | 2,4-Quinazolinediamine, N4-(5-ethyl-1H-pyrazol-3-yl)-N2-[(1S)-1-(4-fluorophenyl)ethyl]- Chemical Properties |
| Boiling point | 612.5±65.0 °C(Predicted) | | density | 1.334±0.06 g/cm3(Predicted) | | pka | 14.27±0.10(Predicted) | | form | Solid | | color | White to off-white |
| | 2,4-Quinazolinediamine, N4-(5-ethyl-1H-pyrazol-3-yl)-N2-[(1S)-1-(4-fluorophenyl)ethyl]- Usage And Synthesis |
| Uses | GRK6-IN-2 (compound 10a) is a potent inhibitor of G protein-coupled receptor kinase 6 (GRK6) with an IC50 of 120 nM. GRK6 is a critical kinase required for the survival of multiple myeloma (MM) cells. GRK6-IN-2 has the potential for the research of multiple myeloma[1]. | | References | [1] Uehling DE, et al. Design, Synthesis, and Characterization of 4-Aminoquinazolines as Potent Inhibitors of the G Protein-Coupled Receptor Kinase 6 (GRK6) for the Treatment of Multiple Myeloma [published correction appears in J Med Chem. 2022 Jan 13;65(1):886-887]. J Med Chem. 2021;64(15):11129-11147. DOI:10.1021/acs.jmedchem.1c00506 |
| | 2,4-Quinazolinediamine, N4-(5-ethyl-1H-pyrazol-3-yl)-N2-[(1S)-1-(4-fluorophenyl)ethyl]- Preparation Products And Raw materials |
|